RA Capital Management, L.P., Director, 10% Owner at Artiva Biotherapeutics, Inc. (ARTV), bought 45,768 shares at $9.99 ($456K) on 2026-07-29, disclosed to the SEC on 2026-07-31.
Open-market purchase of $456k ARTV by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.99 | 20,824 | $208K | 45.6% |
| 2 | $9.93 | 24,944 | $248K | 54.4% |
| Total | $9.96 avg | 45,768 | $456K | 100% |
| Filing → |
| ARTV | BUY | 2026-07-28 | $413K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $58K | — | Filing → |
| ARTV | BUY | 2026-07-23 | $2.6M | — | Filing → |